BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 16730070)

  • 1. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: I. Clinical implications.
    Lara DR; Pinto O; Akiskal K; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):67-87. PubMed ID: 16730070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.
    Lara DR; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire.
    Akiskal HS; Akiskal KK; Haykal RF; Manning JS; Connor PD
    J Affect Disord; 2005 Mar; 85(1-2):3-16. PubMed ID: 15780671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the Combined Emotional and Affective Temperament Scale (CEATS): towards a brief self-rated instrument.
    Lara DR; Lorenzi TM; Borba DL; Silveira LC; Reppold CT
    J Affect Disord; 2008 Dec; 111(2-3):320-33. PubMed ID: 18817978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
    Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.
    Akiskal HS; Mendlowicz MV; Jean-Louis G; Rapaport MH; Kelsoe JR; Gillin JC; Smith TL
    J Affect Disord; 2005 Mar; 85(1-2):45-52. PubMed ID: 15780675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysthymic and anxiety-related personality traits in bipolar spectrum illness.
    Savitz J; van der Merwe L; Ramesar R
    J Affect Disord; 2008 Aug; 109(3):305-11. PubMed ID: 18192025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affective temperaments in clinically-well subjects in Turkey: initial psychometric data on the TEMPS-A.
    Vahip S; Kesebir S; Alkan M; Yazici O; Akiskal KK; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):113-25. PubMed ID: 15780682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of TEMPS-A in a Japanese non-clinical population: application to unipolar and bipolar depressives.
    Matsumoto S; Akiyama T; Tsuda H; Miyake Y; Kawamura Y; Noda T; Akiskal KK; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):85-92. PubMed ID: 15780679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEMPS-A (Rome): psychometric validation of affective temperaments in clinically well subjects in mid- and south Italy.
    Pompili M; Girardi P; Tatarelli R; Iliceto P; De Pisa E; Tondo L; Akiskal KK; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):63-75. PubMed ID: 17884175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament profiles in physicians, lawyers, managers, industrialists, architects, journalists, and artists: a study in psychiatric outpatients.
    Akiskal KK; Savino M; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):201-6. PubMed ID: 15780690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Affective temperaments in the bipolar and unipolar disorders: distinctive profiles and relationship with clinical features].
    Gassab L; Mechri A; Bacha M; Gaddour N; Gaha L
    Encephale; 2008 Oct; 34(5):477-82. PubMed ID: 19068336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective temperaments in heroin addiction.
    Maremmani I; Pacini M; Popovic D; Romano A; Maremmani AG; Perugi G; Deltito J; Akiskal K; Akiskal H
    J Affect Disord; 2009 Oct; 117(3):186-92. PubMed ID: 19201034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociative experiences differentiate bipolar-II from unipolar depressed patients: the mediating role of cyclothymia and the Type A behaviour speed and impatience subscale.
    Oedegaard KJ; Neckelmann D; Benazzi F; Syrstad VE; Akiskal HS; Fasmer OB
    J Affect Disord; 2008 Jun; 108(3):207-16. PubMed ID: 18077000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping.
    Akiskal HS; Akiskal KK; Perugi G; Toni C; Ruffolo G; Tusini G
    J Affect Disord; 2006 Dec; 96(3):239-47. PubMed ID: 16973219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?
    Chiaroni P; Hantouche EG; Gouvernet J; Azorin JM; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):135-45. PubMed ID: 15780684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of affective temperaments in Hungary: internal consistency and concurrent validity of the TEMPS-A against the TCI and NEO-PI-R.
    Rózsa S; Rihmer Z; Gonda X; Szili I; Rihmer A; Ko N; Németh A; Pestality P; Bagdy G; Alhassoon O; Akiskal KK; Akiskal HS
    J Affect Disord; 2008 Feb; 106(1-2):45-53. PubMed ID: 17706791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description and validation of the Affective Temperament Questionnaire.
    Light KJ; Joyce PR; Frampton CM
    Compr Psychiatry; 2009; 50(5):477-84. PubMed ID: 19683619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.